애임스바이오사이언스 애임스바이오사이언스
애임스바이오사이언스 애임스바이오사이언스


AIMS 프로젝트 진행 현황
(2023년 3월 15일 기준)

애임스바이오사이언스 애임스바이오사이언스
Project No. Therapeutic Area Indication Stage Contact Pre-Meeting Contract Ongoing
- Cardiovascular Pulmonary Arterial Hypertension Non-Clinical
- Dermatology Hypertrophic Scar Non-Clinical
CO-2021-133 Endocrinology Type2 Diabetes Mellitus Clinical
CO-2021-208 Wilson's Disease Non-Clinical
CO-2022-129 Gastroenterology Gastroesophageal Reflux Disease Clinical
CO-2021-178 Hepatology Non-Alcoholic Steatohepatitis Clinical
CO-2022-017 Liver Fibrosis Non-Clinical
CO-2022-180 Non-Alcoholic Steatohepatitis Non-Clinical
CO-2023-017 Immunology 자가면역질환치료제 Clinical
CO-2022-060 Neurology Uremia Non-Clinical
- Neurology Alzheimer’s Disease Non-Clinical
CO-2021-039 Oncology Cancer Non-Clinical
CO-2022-001 Liver Cancer Non-Clinical
CO-2022-058 Breast Cancer Non-Clinical
CO-2022-163 Glioblastoma Non-Clinical
CO-2022-197 FLT3-mutated Acute Myeloid Leukemia Non-Clinical
CO-2022-210 Multiple Myeloma Non-Clinical
CO-2020-008 Cancer Non-Clinical
CO-2021-024 Acute Myeloid Leukemia Non-Clinical
CO-2022-218 Solid Tumor Non-Clinical
CO-2023-002 Solid Tumor PCC
CO-2023-006 Solid Tumor Clinical
CO-2023-012 Chronic Myeloid Leukemia Non-Clinical
- Cancer Immunotherapy Non-Clinical
- Solid Tumor Clinical
- Solid Tumor Non-Clinical
- FLT3-mutated Acute Myeloid Leukemia Non-Clinical
- Solid Tumor Non-Clinical
CO-2021-016 Ophthalmology Dry Eye Syndrome Non-Clinical
CO-2022-039 Dry eye syndrome Non-Clinical
CO-2022-200 Respiratory Virus induced Respiratory Disease Non-Clinical
CO-2022-234 Acute Respiratory Distress Syndrome Non-Clinical
CO-2023-005 COPD Non-Clinical
CO-2022-245 Rheumatology Rheumatoid Arthritis Clinical
CO-2021-170 Other - -
CO-2023-018 세포치료제/유전자치료제 Non-Clinical